XML 54 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation Plans (Tables)
6 Months Ended
Jul. 31, 2022
Stock-Based Compensation Plans  
Schedule of estimated stock-based compensation expense recognized in condensed consolidated statement of operations

    

Three Months Ended

    

Six Months Ended

July 31,

    

July 31,

July 31,

    

July 31,

2022

2021

2022

2021

Cost of revenues

 

254

 

199

 

449

 

343

Sales and marketing

 

675

 

918

 

1,160

 

1,279

Research and development

 

490

 

388

 

857

 

668

General and administrative

 

2,317

 

1,510

 

4,057

 

2,877

Effect on net income

 

3,736

 

3,015

 

6,523

 

5,167

Schedule of weighted-average assumptions

    

Six Months Ended

July 31,

    

July 31,

2022

2021

Expected dividend yield (%)

 

 

Expected volatility (%)

 

29.2

 

27.8

Risk-free rate (%)

 

2.4

 

0.7

Expected option life (years)

 

5

 

5

Schedule of stock option activity

    

    

    

Weighted-

    

Number of

Weighted-

Average

Aggregate

Stock

Average

Remaining

Intrinsic

Options

Exercise

Contractual

Value

Outstanding

Price

Life (years)

(in millions)

Balance at January 31, 2022

 

1,319,279

$

42.35

 

4.4

$

41.5

Granted

 

354,699

$

62.57

 

  

 

  

Exercised

 

(32,337)

$

26.51

 

  

 

  

Forfeited

 

(13,663)

$

53.06

 

  

 

  

Balance at July 31, 2022

 

1,627,978

$

46.34

 

4.6

$

37.4

Vested or expected to vest at July 31, 2022

 

1,627,978

$

46.34

 

4.6

$

37.4

Exercisable at July 31, 2022

 

827,223

$

36.69

 

3.5

$

26.9

Summary of performance share units activity

    

    

Weighted-

    

Weighted-

    

Average

Average

Aggregate

Number of

Granted

Remaining

Intrinsic

PSUs

Date Fair

Contractual

Value

Outstanding

Value

Life (years)

(in millions)

Balance at January 31, 2022

 

777,538

$

35.76

 

4.8

$

57.4

Granted

 

97,991

$

66.58

 

  

 

  

Performance units issued

 

39,704

$

55.68

 

  

 

  

Balance at July 31, 2022

 

915,233

$

39.36

 

5.0

$

63.4

Vested or expected to vest at July 31, 2022

 

915,233

$

39.36

 

5.0

$

63.4

Exercisable at July 31, 2022

 

654,467

$

27.43

 

3.6

$

45.3

Summary of restricted share units activity

    

    

Weighted-

    

Weighted-

    

Average

Average

Aggregate

Number of

Granted

Remaining

Intrinsic

RSUs

Date Fair

Contractual

Value

Outstanding

Value

Life (years)

(in millions)

Balance at January 31, 2022

 

410,980

$

29.17

 

5.0

$

30.3

Granted

 

63,651

$

63.05

 

  

 

  

Balance at July 31, 2022

 

474,631

$

33.24

 

5.1

$

32.9

Vested or expected to vest at July 31, 2022

 

474,631

$

33.24

 

5.1

$

32.9

Exercisable at July 31, 2022

 

355,675

$

24.17

 

3.9

$

24.6

Summary cash settled restricted share unit plan activity

    

    

Weighted-

Average

Number of

Remaining

CRSUs

Contractual

Outstanding

Life (years)

Balance at January 31, 2022

 

24,428

 

1.4

Granted

 

7,948

 

  

Vested and settled in cash

 

(9,463)

 

  

Forfeited

 

(74)

 

  

Balance at July 31, 2022

 

22,839

 

1.6

Non-vested at July 31, 2022

 

22,839

 

1.6